← Browse by Condition
Medical Condition

systemic scleroderma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT03816345 Phase 1
Recruiting

Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer

Enrollment
300 pts
Location
United States, Canad...
Sponsor
National Cancer Institute (NCI...
View Trial →